Oxford Square Capital | 8-K: FY2025 Q3 Revenue Beats Estimate at USD 10.24 M

Revenue: As of FY2025 Q3, the actual value is USD 10.24 M, beating the estimate of USD 9.599 M.

EPS: As of FY2025 Q3, the actual value is USD -0.03, missing the estimate of USD 0.07.

EBIT: As of FY2025 Q3, the actual value is USD 2.956 M.

Segment Revenue

• Total investment income for the quarter ended September 30, 2025, was approximately $10.2 million, compared to $9.5 million for the quarter ended June 30, 2025.
• Investment income from debt investments was $5.2 million, from CLO equity investments was $4.3 million, and from other income was $0.8 million.

Operational Metrics

• Net investment income (NII) for the quarter ended September 30, 2025, was approximately $5.6 million, or $0.07 per share, compared to approximately $5.5 million, or $0.08 per share, for the quarter ended June 30, 2025.
• Total expenses for the quarter ended September 30, 2025, were approximately $4.7 million, compared to $4.0 million for the quarter ended June 30, 2025.
• Net decrease in net assets resulting from operations was approximately $2.1 million, consisting of NII of approximately $5.6 million, net realized losses of approximately $153,000, and net unrealized depreciation of approximately $7.5 million.

Cash Flow

• No specific cash flow figures were provided in the reference text.

Unique Metrics

• The weighted average yield of debt investments was 14.6% at current cost, compared to 14.5% as of June 30, 2025.
• The weighted average effective yield of CLO equity investments at current cost was 9.7%, compared to 8.8% as of June 30, 2025.

Outlook / Guidance

• The company announced a 12-month share repurchase program, authorizing up to $25.0 million in repurchases of outstanding common stock, effective from October 30, 2025, to October 30, 2026.
• The timing, manner, price, and amount of any share repurchases will be determined based on economic and market conditions, stock price, and other factors.